MTP IV: Lymphoma 2 

Session Chair: Jasmine M. Zain, MD

• Understanding the Risk of Second Malignancies After CART Therapies | Jaehyuk Choi, MD, PhD | UT Southwestern Medical Center, Dallas, Texas, USA
• Approaching Management of Rare T Cell Lymphomas With Focus on Biology | Stefan Barta, MD | University of Pennsylvania, Philadelphia, Pennsylvania, USA
• Digestive T Cell Lymphomas (EATL, MEATL) | Olivier Hermine, MD, PhD | Imagine Institute, Pairs, France